Immunotherapy : Impact Factor & More
eISSN: 1750-7448pISSN: 1750-743X
Share this on:
Key Metrics
CiteScore 
5.7
Eigenfactor
0.005 - 0.01
H-Index
59
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.7
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Immunotherapy
Immunotherapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Immunotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Immunotherapy
Cancer-induced neuronal injury as a driver of immunotherapy resistance.
- 18 May 2026
- Immunotherapy
Recent developments in nanotechnology-enhanced immunotherapy for glioblastoma.
- 16 May 2026
- Immunotherapy
Clinical determinants and biomarkers for predicting chemotherapeutic response in advanced non-small cell lung cancer: a single-center retrospective study.
- 12 May 2026
- Immunotherapy
Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engager.
- 4 May 2026
- Immunotherapy
Next-generation cancer immunotherapy: the promise of CAR T-Cell therapy.
- 4 May 2026
- Immunotherapy
Correction.
- 28 Apr 2026
- Immunotherapy
Cancer-induced neuronal injury as a driver of immunotherapy resistance.
- 18 May 2026
- Immunotherapy
Recent developments in nanotechnology-enhanced immunotherapy for glioblastoma.
- 16 May 2026
- Immunotherapy
Clinical determinants and biomarkers for predicting chemotherapeutic response in advanced non-small cell lung cancer: a single-center retrospective study.
- 12 May 2026
- Immunotherapy
Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engager.
- 4 May 2026
- Immunotherapy
Next-generation cancer immunotherapy: the promise of CAR T-Cell therapy.
- 4 May 2026
- Immunotherapy
Correction.
- 28 Apr 2026
- Immunotherapy
FAQs on Immunotherapy
How long has Immunotherapy been actively publishing? 
What is the publishing frequency of Immunotherapy?
How many articles did Immunotherapy publish last year?
What is the eISSN & pISSN for Immunotherapy?
What is Citescore for Immunotherapy?
What is the H Index for Immunotherapy ?
What is SNIP score for Immunotherapy?
What is the SJR for Immunotherapy?
Who is the publisher of Immunotherapy?
